Rockefeller Capital Management
IDYA icon

Rockefeller Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Rockefeller Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7K Sell
532
-3,263
-86% -$109K ﹤0.01% 3755
2025
Q4 		$131K Buy
3,795
+3,471
+1,071% +$111K ﹤0.01% 2580
2025
Q3 		$8.82K Buy
+324
New +$7.84K ﹤0.01% 3699

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Rockefeller Capital Management's IDYA Position: Q1 2026 in Review

Rockefeller Capital Management reduced its IDEAYA Biosciences (IDYA) stake by 86% in Q1 2026, selling an estimated $109K and leaving 532 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3755.

Rockefeller Capital Management first reported a position in IDYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $131K in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Rockefeller Capital Management held 532 shares of IDEAYA Biosciences worth $17.7K as of Q1 2026.
  • Rockefeller Capital Management sold 3,263 IDEAYA Biosciences shares in Q1 2026, an estimated $109K.
  • IDEAYA Biosciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3755 holding.
  • Rockefeller Capital Management first reported a position in IDEAYA Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's IDEAYA Biosciences position peaked at $131K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.